Chapter 1. Indian Pharmaceutical Market Overview
1.1 Scale of Pharmaceutical Market
1.1.1 Domestic pharmaceutical market
India is among the fastest growing pharmaceutical markets in the world. The domestic pharmaceutical market recorded sales of US$ 7.3 billion in 2006 with a growth of 17.5 per cent over the previous year.
1.1.2 Pharmaceutical Industry
The Indian pharmaceutical industry
I. Introduction of Hanmi
Hanmi is pharmaceutical company spearheading innovation in life science. Hanmi was established by Lim,Sung Gi in 1973 based on mottoes –“Human Respect” & “Creation of Value”, Hanmi has endless exerted all its power for precious human life. For the purpose of the progress of pharmaceutical industry and the supply of highly qualified medicines with the most
pharmaceutical product is not valuable, inexpensive, easy to get.
Bargaining
Power of buyers
Low Before the prescription regulations buyers can get pills more easily.
But after prescription requirement regulations their option decreased.
Threat of
substitute
Low It can say “ there are no substitute”
Because of high regulations, product which have
pharmaceutical industry.
(1)-2 The changes of the drug pricing system
In 1958 the minister of labor welfare has established the current drug pricing system which determines the purchase price and is updated every 2 years.
The introduction of the Bulk Line method: by using the drug price investigation results as a reference, we line up the lowest trading costs of individua
1. History and introduction of Dong A pharmaceutical
Dong-A Pharmaceutical is the leading pharmaceutical company in Korea. Dong-A stands at the forefront of Korea's pharmaceutical industry; motivated by its respect for life and health to continuously innovate and develop products that enhance people's quality of life. We are working hard to grow internationally and become one of the world's most